Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Chromosome Dynamics EBITDA Margin % Related Terms
Chromosome Dynamics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Chromosome Dynamics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chromosome Dynamics EBITDA Margin % Chart
Chromosome Dynamics Annual Data
Trend
EBITDA Margin %
Chromosome Dynamics Semi-Annual Data
EBITDA Margin %
BSE:CHRD vs QH, SHOP, UBER: EBITDA Margin % Comparison
For the Software - Application subindustry, Chromosome Dynamics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chromosome Dynamics EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Chromosome Dynamics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Chromosome Dynamics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chromosome Dynamics (BSE:CHRD) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chromosome Dynamics and its competitors. According to the industry distribution chart, Chromosome Dynamics ranks #999999 out of 2824 companies in the Software industry.
Is Chromosome Dynamics' EBITDA Margin % too high?
Chromosome Dynamics' current EBITDA Margin % is 0.00%. Based on the distribution chart, Chromosome Dynamics ranks #999999 out of 2824 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Chromosome Dynamics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Chromosome Dynamics' EBITDA Margin % compare to QH and SHOP?
According to the Software industry distribution chart, Chromosome Dynamics ranks #999999 out of 2824 companies for EBITDA Margin %. This places Chromosome Dynamics in the lower half of its industry. The industry median EBITDA Margin % is 8.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.18, based on 2,824 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chromosome Dynamics and its competitors. For the Software industry, the median EBITDA Margin % is 8.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chromosome Dynamics's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chromosome Dynamics stock overvalued right now?
Chromosome Dynamics (BSE:CHRD) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Chromosome Dynamics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Chromosome Dynamics (BSE:CHRD), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chromosome Dynamics is an integrated agribusiness development and research company focused on innovative IT and AI solutions that aims to reconfigure the processes, solutions and perspectives of farmers. It engages in designing business plans for agricultural input distribution companies, training sales teams through technical courses, product development and marketing for agriculture (fertilizers, biostimulators, pesticides), assistance, and consulting. it offers various products namely Spellbox, Agrobazar Marketplace, CHRDAds, Rooster's Journey, Homeland, Tortoise, and ORGNit.
32GF Score
Get the complete analysis for BSE:CHRD
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:CHRD has been successfully added to your 
